139480.KS
E-MART Inc.
KSEKRWEQUITY
Consumer Defensive
DELAYED
Last price
72,700.00
▲ 800.00 (1.11%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
71,900.00
Prev close
71,900.00
Day high
73,100.00
Day low
71,700.00
Volume
79.81K
Market cap
$1.94T
P/E (TTM)
—
52W range
70,300.00 – 136,400.00
Day trading desk
Gap from prior close
0.00%
Prior close 71,900.00
VWAP
72,249.66
+0.62% from price
Relative volume
0.53×
Quiet session
Session range
1.95%
71,700.00 – 73,100.00
Position in range
71%
Near session high
ATR (14D)
2,521.43
3.47% of price
Prior day high
72,400.00
PDH
Prior day low
70,800.00
PDL
Bid / ask spread
—
Quote not published
Session volume
79.97K
Avg 150.82K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-8.11%
-6.7%
1M
-13.07%
-16.8%
3M
-22.71%
-25.8%
6M
-34.86%
-45.9%
YTD
-10.82%
-23.1%
1Y
-19.80%
-39.8%
3Y
-6.33%
-80.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 139480.KS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
7.73M
Total on file
Fundamentals
Market cap$1.94T
Enterprise value$14.46T
Revenue (TTM)$28.75T
Gross profit$8.84T
EBITDA$1.71T
Net income$21.22B
EPS (TTM)—
Free cash flow$-333.76B
Total cash$2.89T
Total debt$12.76T
Book value / share—
Shares outstanding26.79M
Float16.04M
Short % of float—
Dividend yield3.48%
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue0.50
EV / EBITDA8.47
Gross margin30.73%
Operating margin-0.63%
Profit margin0.07%
Return on equity0.94%
Return on assets0.41%
Debt / equity80.76
Current ratio0.62
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $28.97T | $29.02T | $29.47T | $29.33T | -0.2% |
| Operating revenue | $28.97T | $29.02T | $29.47T | $29.33T | -0.2% |
| Cost of revenue | $19.88T | $19.98T | $20.73T | $21.01T | -0.5% |
| Gross profit | $9.09T | $9.04T | $8.74T | $8.32T | +0.6% |
| Selling, general & admin | $3.61T | $3.53T | $3.63T | $3.24T | +2.3% |
| Total operating expense | $8.77T | $9.01T | $8.79T | $8.19T | -2.6% |
| Operating income | $322.95B | $34.87B | -$45.59B | $136.64B | +826.3% |
| Net interest income | -$397.69B | -$365.55B | -$322.30B | -$258.52B | -8.8% |
| Pre-tax income | $376.38B | -$605.41B | -$212.29B | $1.25T | +162.2% |
| Tax provision | $130.04B | -$31.98B | -$24.82B | $244.76B | +506.6% |
| Net income | $136.19B | -$590.02B | -$89.09B | $1.03T | +123.1% |
| Net income to common | $136.19B | -$590.02B | -$89.09B | $1.03T | +123.1% |
| Basic EPS | 5,084.00 | -22,240.00 | -3,864.00 | 37,528.00 | +122.9% |
| Diluted EPS | 5,084.00 | -22,240.00 | -3,864.00 | 37,528.00 | +122.9% |
| EBIT | $894.35B | -$111.68B | $205.39B | $1.57T | +900.8% |
| EBITDA | $2.38T | $1.52T | $1.80T | $3.13T | +57.2% |
| Basic shares | 26.79M | 26.53M | 23.06M | 27.43M | +1.0% |
| Diluted shares | 26.79M | 26.53M | 23.06M | 27.43M | +1.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.30T | $1.78T | $1.77T | $1.27T | -26.6% |
| Cash & short-term investments | $2.13T | $2.12T | $2.45T | $1.73T | +0.2% |
| Accounts receivable | $1.14T | $1.25T | $1.34T | $1.06T | -9.3% |
| Inventory | $2.09T | $2.05T | $1.85T | $2.03T | +1.7% |
| Total current assets | $6.23T | $10.43T | $6.39T | $5.85T | -40.3% |
| Property, plant & equipment | $12.48T | $12.84T | $13.17T | $13.53T | -2.8% |
| Goodwill & intangibles | $3.94T | $4.10T | $7.76T | $7.76T | -3.9% |
| Total assets | $33.50T | $33.93T | $33.44T | $33.20T | -1.3% |
| Total current liabilities | $10.07T | $10.80T | $10.37T | $9.94T | -6.8% |
| Current debt | $3.11T | $3.17T | $3.13T | $2.66T | -1.7% |
| Long-term debt | $5.49T | $5.75T | $4.74T | $4.68T | -4.6% |
| Total debt | $11.93T | $12.50T | $11.54T | $10.99T | -4.6% |
| Total liabilities | $19.81T | $20.85T | $19.61T | $19.72T | -5.0% |
| Retained earnings | $4.71T | $4.64T | $5.36T | $5.69T | +1.4% |
| Shareholder equity | $11.00T | $10.39T | $11.45T | $11.21T | +5.9% |
| Working capital | -$3.84T | -$374.99B | -$3.99T | -$4.09T | -924.6% |
| Net tangible assets | $7.06T | $6.29T | $3.69T | $3.45T | +12.2% |
| Shares issued | 26.79M | 27.88M | 27.88M | 27.88M | -3.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $246.34B | -$573.43B | -$212.29B | $1.25T | +143.0% |
| Depreciation & amortisation | $1.49T | $1.63T | $1.60T | $1.56T | -8.5% |
| Change in working capital | -$632.44B | -$372.18B | -$353.37B | -$581.85B | -69.9% |
| Operating cash flow | $1.32T | $1.46T | $1.14T | $745.72B | -9.7% |
| Capital expenditure | -$781.48B | -$704.32B | -$853.67B | -$1.23T | -11.0% |
| Investing cash flow | -$1.07T | -$892.12B | -$809.13B | -$714.37B | -19.9% |
| Share buybacks | -$389.13M | — | -$447.00K | -$134.40B | — |
| Dividends paid | -$189.34B | -$171.94B | -$146.41B | -$127.78B | -10.1% |
| Financing cash flow | -$858.03B | -$153.07B | $176.05B | $221.92B | -460.5% |
| Free cash flow | $537.46B | $755.49B | $281.46B | -$484.44B | -28.9% |
| End cash position | $1.30T | $1.78T | $1.77T | $1.27T | -26.6% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $7.12T | $7.31T | $7.40T | $7.04T | $7.22T | -2.6% |
| Operating revenue | $7.12T | $7.31T | $7.40T | $7.04T | $7.22T | -2.6% |
| Cost of revenue | $4.92T | $4.99T | $5.10T | $4.84T | $4.95T | -1.4% |
| Gross profit | $2.20T | $2.32T | $2.30T | $2.20T | $2.27T | -5.0% |
| Selling, general & admin | $780.37B | $989.06B | $914.28B | $857.31B | $847.96B | -21.1% |
| Total operating expense | $2.02T | $2.33T | $2.15T | $2.18T | $2.11T | -13.1% |
| Operating income | $178.34B | -$9.86B | $151.47B | $21.62B | $159.72B | +1,909.4% |
| Net interest income | -$96.44B | -$101.89B | -$96.67B | -$98.34B | -$100.79B | +5.3% |
| Pre-tax income | $115.52B | -$60.57B | $344.20B | -$26.42B | $119.17B | +290.7% |
| Tax provision | $36.13B | $55.68B | $33.86B | $4.94B | $35.56B | -35.1% |
| Net income | $59.78B | -$148.23B | $265.92B | -$52.26B | $70.76B | +140.3% |
| Net income to common | $59.78B | -$148.23B | $265.92B | -$52.26B | $70.76B | +140.3% |
| Basic EPS | 2,232.00 | — | 9,927.00 | -1,951.00 | 2,641.00 | — |
| Diluted EPS | 2,232.00 | — | 9,927.00 | -1,951.00 | 2,641.00 | — |
| EBIT | $245.29B | $69.55B | $471.54B | $103.91B | $249.35B | +252.7% |
| EBITDA | $608.16B | $442.61B | $846.01B | $475.16B | $619.85B | +37.4% |
| Basic shares | 26.79M | — | 26.79M | 26.79M | 26.79M | — |
| Diluted shares | 26.79M | — | 26.79M | 26.79M | 26.79M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.18T | $1.30T | $1.65T | $1.06T | $1.22T | -9.2% |
| Cash & short-term investments | $2.95T | $2.13T | $2.40T | $1.78T | $1.86T | +38.7% |
| Accounts receivable | $35.09B | $1.14T | $60.40B | $56.11B | $55.33B | -96.9% |
| Inventory | $2.17T | $2.09T | $2.17T | $2.00T | $2.01T | +3.8% |
| Total current assets | $7.21T | $6.23T | $10.99T | $10.21T | $10.43T | +15.8% |
| Property, plant & equipment | $12.06T | $12.48T | $12.71T | $12.64T | $12.74T | -3.4% |
| Goodwill & intangibles | $3.95T | $3.94T | $3.99T | $4.00T | $4.07T | +0.4% |
| Total assets | $34.88T | $33.50T | $34.91T | $33.97T | $33.65T | +4.1% |
| Total current liabilities | $10.95T | $10.07T | $10.99T | $11.11T | $11.22T | +8.7% |
| Current debt | $3.98T | $3.11T | $2.90T | $3.74T | $3.77T | +28.0% |
| Long-term debt | $5.35T | $5.49T | $5.54T | $5.11T | $5.06T | -2.5% |
| Total debt | $9.33T | $11.93T | $11.96T | $8.85T | $8.83T | -21.8% |
| Total liabilities | $20.75T | $19.81T | $21.01T | $20.63T | $20.61T | +4.8% |
| Retained earnings | $4.68T | $4.71T | $4.84T | $4.57T | $4.66T | -0.4% |
| Shareholder equity | $11.57T | $11.00T | $11.10T | $10.53T | $10.24T | +5.2% |
| Working capital | -$3.74T | -$3.84T | -$6.26B | -$901.79B | -$795.28B | +2.8% |
| Net tangible assets | $7.62T | $7.06T | $7.11T | $6.53T | $6.17T | +7.9% |
| Shares issued | 27.60M | 26.79M | 27.60M | 27.60M | 27.88M | +3.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $79.39B | -$190.61B | $344.20B | $9.14B | $83.61B | +141.7% |
| Depreciation & amortisation | $362.87B | $373.05B | $374.47B | $371.25B | $370.50B | -2.7% |
| Change in working capital | -$259.27B | -$462.36B | $449.00B | -$97.02B | -$522.07B | +43.9% |
| Operating cash flow | $257.19B | $48.00B | $963.14B | $339.50B | -$31.71B | +435.8% |
| Capital expenditure | -$124.65B | -$197.84B | -$180.07B | -$201.85B | -$201.72B | +37.0% |
| Investing cash flow | -$1.01T | -$320.68B | $153.32B | -$439.94B | -$462.27B | -216.1% |
| Share buybacks | -$74.02M | $0 | -$338.64M | $0 | -$50.49M | — |
| Dividends paid | -$32.91B | -$12.93B | -$51.46B | -$91.82B | -$33.12B | -154.5% |
| Financing cash flow | $632.08B | -$140.72B | -$462.05B | -$80.98B | -$174.28B | +549.2% |
| Free cash flow | $132.54B | -$149.84B | $783.07B | $137.65B | -$233.42B | +188.5% |
| End cash position | $1.18T | $1.30T | $1.65T | $1.06T | $1.22T | -9.2% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -2,544.31 | -5,833.00 | -129.3% |
| Mar 2026 | 3,392.03 | 2,241.93 | -33.9% |
| Dec 2025 | 1,241.74 | -5,533.00 | -545.6% |
| Sep 2025 | 2,339.56 | 9,927.00 | +324.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 12,983.75 | 1 | $7.43T | +0.4% |
| Next quarter | -3,940.20 | 1 | $7.41T | +1.4% |
| Current year | -291.95 | 6 | $28.82T | +86.1% |
| Next year | 8,611.23 | 10 | $30.13T | +65.9% |
Analyst targets & ownership
Mean target$115,583.34
High target$160,000.00
Low target$65,000.00
Implied upside58.99%
Analyst count12
ConsensusBUY
Strong buy / Buy2 / 7
Hold2
Sell / Strong sell0 / 1
Held by insiders28.87%
Held by institutions21.45%
Institutions holding101
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
76,480.00
-4.94% from price
SMA 20
78,125.00
-7.20% from price
SMA 50
81,048.00
-10.55% from price
SMA 100
89,301.00
-18.59% from price
SMA 200
88,935.00
-18.48% from price
EMA 12
75,914.51
-4.23% from price
EMA 26
78,299.39
-7.15% from price
EMA 50
81,486.32
-10.78% from price
RSI (14)
33.9
Neutral
MACD (12,26,9)
-2,384.88
Hist -708.42
ATR (14)
2,521.43
3.48% of price
Realised vol 30D
38.8%
Annualised
Bollinger upper
84,707.06
20, 2σ
Bollinger lower
71,542.94
20, 2σ
50 / 200 cross
Death
81,048.00 vs 88,935.00
Trend bias
Below 200
-18.48%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.31
Less volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
38.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-43.7%
Peak to trough
Max drawdown 5Y
-69.3%
Peak to trough
ATR 14
2,521.43
3.48% of price
Beta (reported)
—
5Y monthly, from filing
Dividends & splits
Forward rate$2,500.00 / yr
Forward yield3.48%
5-year avg yield1.74%
Payout ratio315.66%
Ex-dividend dateMar 31, 2026
Next pay date—
Last split—
Split date—
Headlines
Billionaire Investor Stanley Druckenmiller Sold Broadcom, Intel, and Micron and Bought Another Chip Stock That Expects to Double Data Center Sales in 2027
Motley Fool · 12m ago
TME Pharma provides update on its activities
GlobeNewswire · 12m ago
American Chemical Society Names Syngenta's Camilla Corsi the 2026 Winner of Prestigious International Award for Research in Agrochemicals
Business Wire · 17m ago
Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and €40.25 Million PIPE Financing From New and Existing Investors
Business Wire · 17m ago
Board Update
GlobeNewswire · 17m ago
Aegon implements EUR 150 million increase in share buyback program
GlobeNewswire · 17m ago
TOMY's "TOMICA XROSS RESCUE" Diorama-based Short Animation Series to Begin Streaming Aug. 26, 2026
PR Newswire · 17m ago
Holding(s) in Company
GlobeNewswire · 17m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.